Table 4 Adverse events after SARS-CoV-2 vaccination
Controls | Adolescents with RD | |
|---|---|---|
AE after 1º dose | ||
Local | 13 (54%) | 20 (50%) |
None | 7 (30%) | 11 (28%) |
Asthenia | 1 (4%) | 2 (5%) |
Low grade fever | 2 (8%) | 2 (5%) |
Not reported | 1 (4%) | 5 (12%) |
AE after 2º dose n (%) | ||
Low grade fever | 4 (17%) | 8 (20%) |
Local | 2 (8%) | 8 (20%) |
Asthenia | 2 (8%) | 7 (18%) |
None | 1 (4%) | 3 (8%) |
Menstrual disorder | 0 | 1 (2%) |
Not reported | 11 (46%) | 9 (22%) |
Not applicable | 4 (17%) | 4 (10%) |